期刊
CLINICAL BIOCHEMISTRY
卷 41, 期 14-15, 页码 1224-1236出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.clinbiochem.2008.07.012
关键词
Proteomics; colorectal cancer; CLIC1; TPD52; ANXA5
资金
- Forschungforderungsprogramm 2005 University Medical Center Gottingen, Germany
- Bulgarian consortium for structural genomics and in silico drug design [DRI-5-2006]
Objectives: Unequivocal biomarkers are needed to predict susceptibility and progression of colorectal cancer. Design and methods: Paired samples of tumor and normal tissue from six patients with colorectal cancer of different localization, pTNM stage and grade were employed in the present study. MS analysis was used to identify differentially regulated proteins after 2-DE separation and densitometric analysis. Results: Densitometric analysis revealed differential abundance of 55 spots in tumor as compared to normal tissues. Thirty nine out of 55 spots were unambiguously identified by MS representing 32 different proteins. CLIC1, TPD52 and FABPL were consistently overexpressed (>3-fold, P<0.05) in all tumor tissue samples, while TPM1, TPM2, TPM3, TAGL and MLRN were consistently down-regulated (>3-fold, P<0.05) compared to normal tissue. Conclusions: CLIC1 and TPD52 were significantly (P<0.05) up-regulated in all cases of colorectal cancer investigated, irrespective of localization, pTNM stage and grade of colon cancer highlighting their potential to serve as new biomarkers. (C) 2008 The Canadian Society of Clinical Chemist. Published by Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据